Dermira (NASDAQ: DERM) reported Q3 EPS of ($0.12), $0.05 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $14.63 million versus the consensus estimate of $14.4 million.

For earnings history and earnings-related data on Dermira (DERM) click here.